BMRN BioMarin Pharmaceutical Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
11:56
Aug 31
Aug 31
Premarket movers show Mag 7 mixed with NVDA up, BioMarin rising on patent settlement.
Premarket movers show Mag 7 mixed with NVDA up, BioMarin rising on patent settlement, energy stocks higher on Middle East tensions, Kaiser upgraded to buy, PG&E and Edison falling on wildfire bill, Pinterest down on CFO departure, SAIC up on guidance, and SLB acquiring Kelvion.
11:28
Aug 17
Aug 17
A news wire reports a broad list of price target increases across dozens of stocks from various.
A news wire reports a broad list of price target increases across dozens of stocks from various analysts, with no directional commentary or personal market views expressed.
21:12
Jan 23
Jan 23
BioMarin has predictable growing cash flows
He avoids most biotechs except those with predictable and growing cash flows. BioMarin fits that exception and is periodically bought in his rotation.
MED
About BMRN Investor Commentary
Across the available history and selected sources, Buzzberg tracks BMRN (BioMarin Pharmaceutical) across 3 sources: 1 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 33% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Latest voices: zerohedge, DeItaone, Dmitry Solodin.